LPL Financial LLC Has $257.73 Million Stake in Intuitive Surgical, Inc. $ISRG

LPL Financial LLC boosted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 455,070 shares of the medical equipment provider’s stock after buying an additional 22,774 shares during the period. LPL Financial LLC’s holdings in Intuitive Surgical were worth $257,734,000 as of its most recent SEC filing.

Other hedge funds have also recently bought and sold shares of the company. Newbridge Financial Services Group Inc. increased its position in Intuitive Surgical by 300.0% during the fourth quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 33 shares during the last quarter. Holos Integrated Wealth LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $25,000. Olistico Wealth LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $28,000. Laurel Wealth Advisors LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $31,000. Finally, Turning Point Benefit Group Inc. increased its position in Intuitive Surgical by 833.3% during the fourth quarter. Turning Point Benefit Group Inc. now owns 56 shares of the medical equipment provider’s stock worth $32,000 after buying an additional 50 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the sale, the senior vice president directly owned 6,463 shares of the company’s stock, valued at $2,718,014.65. This trade represents a 46.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 119 shares of Intuitive Surgical stock in a transaction dated Wednesday, April 29th. The stock was sold at an average price of $463.50, for a total value of $55,156.50. Following the sale, the director directly owned 120 shares in the company, valued at approximately $55,620. This trade represents a 49.79% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 6,698 shares of company stock valued at $2,859,708 over the last three months. 0.60% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of several analyst reports. Mizuho set a $525.00 target price on shares of Intuitive Surgical and gave the stock a “neutral” rating in a research report on Monday, April 13th. Leerink Partners lowered their price target on Intuitive Surgical from $622.00 to $573.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 22nd. Bank of America lowered their price target on Intuitive Surgical from $650.00 to $520.00 and set a “buy” rating on the stock in a research report on Monday, May 18th. Piper Sandler reaffirmed an “overweight” rating and issued a $580.00 price target on shares of Intuitive Surgical in a research report on Tuesday, June 2nd. Finally, Robert W. Baird raised their price target on Intuitive Surgical from $575.00 to $610.00 and gave the company an “outperform” rating in a research report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $573.63.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Intuitive Surgical was upgraded to Zacks Rank #2 (Buy), which signals improved earnings expectations and may support the stock in the near term. Article: Intuitive Surgical (ISRG) Upgraded to Buy: Here’s Why
• Positive Sentiment: Another note said ISRG can expand margins through scale, cost discipline, and adoption of the da Vinci 5 system, helping offset tariff and inflation pressures. Article: Will ISRG’s Cost Leverage Aid Margins Amid Tariff & Input Inflation?
• Neutral Sentiment: Analysts reset their fair value estimate lower, from $611.82 to $565.25, reflecting a more cautious valuation view even while long-term growth optimism remains intact. Article: How The Intuitive Surgical (ISRG) Narrative Is Shifting With Reset Valuations And Mixed Analyst Views
• Neutral Sentiment: Coverage also noted that Medtronic is still trying to challenge Intuitive Surgical’s dominance in robotic surgery, keeping competitive pressure in view. Article: Can Medtronic Finally Challenge Intuitive Surgical’s Robotic Surgical Systems Dominance?

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $426.61 on Wednesday. The company has a market cap of $151.09 billion, a P/E ratio of 51.71, a P/E/G ratio of 3.34 and a beta of 1.46. The stock’s 50-day moving average is $445.72 and its 200-day moving average is $498.83. Intuitive Surgical, Inc. has a 52-week low of $396.68 and a 52-week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share for the quarter, beating the consensus estimate of $2.08 by $0.42. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The business had revenue of $2.77 billion during the quarter, compared to analysts’ expectations of $2.62 billion. During the same quarter last year, the company earned $1.81 earnings per share. The firm’s revenue was up 23.0% on a year-over-year basis. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 8.57 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.